FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 63 filers reported holding FOGHORN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361,235 | -41.9% | 72,247 | -18.2% | 0.00% | – |
| Q2 2023 | $622,111 | +7.2% | 88,368 | -5.6% | 0.00% | – |
| Q1 2023 | $580,115 | -69.8% | 93,567 | -69.0% | 0.00% | – |
| Q4 2022 | $1,923,991 | -78.4% | 301,566 | -70.9% | 0.00% | -100.0% |
| Q3 2022 | $8,890,000 | -46.5% | 1,036,115 | -15.2% | 0.00% | -50.0% |
| Q2 2022 | $16,612,000 | +6.0% | 1,221,462 | +18.7% | 0.00% | 0.0% |
| Q1 2022 | $15,668,000 | +24.1% | 1,028,726 | +86.4% | 0.00% | 0.0% |
| Q4 2021 | $12,622,000 | -7.5% | 551,905 | -43.6% | 0.00% | 0.0% |
| Q3 2021 | $13,641,000 | +30.4% | 979,227 | -0.1% | 0.00% | +100.0% |
| Q2 2021 | $10,460,000 | +101.5% | 980,209 | +149.0% | 0.00% | 0.0% |
| Q1 2021 | $5,190,000 | +498.6% | 393,722 | +821.1% | 0.00% | – |
| Q4 2020 | $867,000 | – | 42,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $28,845,000 | 16.40% |
| Birchview Capital, LP | 314,143 | $7,184,000 | 4.63% |
| Flagship Pioneering Inc. | 12,674,120 | $289,857,000 | 4.48% |
| Monashee Investment Management LLC | 240,000 | $5,489,000 | 1.36% |
| Artal Group S.A. | 1,720,720 | $39,353,000 | 1.07% |
| EAM Investors, LLC | 149,280 | $3,414,000 | 0.56% |
| EAM Global Investors LLC | 103,241 | $2,361,000 | 0.42% |
| Alphabet Inc. | 500,901 | $11,456,000 | 0.28% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 54,341 | $1,243,000 | 0.14% |
| Sunbelt Securities, Inc. | 24,740 | $334,000 | 0.05% |